Chemomab Therapeutics (CMMB) Shareholder's Equity Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.89% |
| Sep 30, 2025 | -31.17% |
| Jun 30, 2025 | -2.86% |
| Mar 31, 2025 | -22.04% |
| Dec 31, 2024 | -20.36% |
| Sep 30, 2024 | -9.56% |
| Jun 30, 2024 | -54.60% |
| Mar 31, 2024 | -52.31% |
| Dec 31, 2023 | -53.08% |
| Sep 30, 2023 | -59.57% |
| Jun 30, 2023 | -57.58% |
| Mar 31, 2023 | -51.16% |
| Dec 31, 2022 | -41.07% |
| Sep 30, 2022 | -31.88% |
| Jun 30, 2022 | -23.81% |
| Mar 31, 2022 | 3.76% |
| Dec 31, 2021 | 469.02% |
| Sep 30, 2021 | 438.88% |
| Jun 30, 2021 | 431.72% |
| Mar 31, 2021 | 414.40% |
| Dec 31, 2020 | -12.70% |
| Sep 30, 2020 | 110.47% |
| Jun 30, 2020 | -53.04% |
| Mar 31, 2020 | -65.78% |
| Dec 31, 2019 | 26.19% |
| Sep 30, 2019 | -56.20% |
| Jun 30, 2019 | 138.00% |
| Dec 31, 2018 | 1,710.02% |